Lungs News and Research

RSS

Gene therapy improves lung function in patients with cystic fibrosis

Gene therapy was shown to provide significant benefits for patients with cystic fibrosis in a recent clinical study published in The Lancet Respiratory Medicine journal.

3 Jul 2015

Gene therapy for cystic fibrosis shows significant benefit in lung function

For the first time gene therapy for cystic fibrosis has shown a significant benefit in lung function compared with placebo, in a phase 2 randomised trial published in The Lancet Respiratory Medicine journal. The technique replaces the defective gene response for cystic fibrosis by using inhaled molecules of DNA to deliver a normal working copy of the gene to lung cells.

3 Jul 2015

Boehringer Ingelheim’s Spiolto Respimat approved for COPD treatment in first European countries

Boehringer Ingelheim today announced regulatory authority approvals for Spiolto Respimat (tiotropium/olodaterol) in first European countries. Spiolto Respimat is a once-daily maintenance treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).

3 Jul 2015

NDSU's Stephen O'Rourke awarded NIH grant to conduct cardiovascular research

Stephen O'Rourke, professor of pharmaceutical sciences at North Dakota State University, Fargo, has received a $435,000 grant from the National Heart, Lung and Blood Institute of the National Institutes of Health to conduct cardiovascular research.

3 Jul 2015

New study finds that cancer survivors who smoke have more barriers to quitting

Cancer survivors who smoke report fewer negative opinions about smoking, have more barriers to quitting, and are around other smokers more often than survivors who had quit before or after their diagnosis, according to a new study appearing in Psycho-Oncology.

3 Jul 2015

FDA accepts Adaptimmune’s IND application for MAGE-A10 T therapeutic candidate to combat NSCLC

Adaptimmune Therapeutics plc, a clinical stage biopharmaceutical company focused on the use of T-cell therapy to treat cancer, today announced that the U.S. Food and Drug Administration has accepted the Company's investigational new drug (IND) application for autologous genetically modified T-cells expressing enhanced T cell receptors specific for MAGE A10 (MAGE-A10 T) in patients with locally advanced or metastatic non-small cell lung cancer, and that the IND is now active.

2 Jul 2015

Mortality rates vary depending on socioeconomic differences among areas in Europe

For a number of years now, scientific literature has questioned whether mortality rates depend on socioeconomic differences among the population. Recently, a new study carried out in 15 European cities - including Barcelona and Madrid - detected inequalities for the majority of causes, concluding that higher levels of poverty are associated with higher mortality rates and there is a great deal of variation among areas.

2 Jul 2015

UCLA patient successfully receives smaller Total Artificial Heart

A petite 44-year-old woman has received a successful heart transplant at Ronald Reagan UCLA Medical Center, thanks to an experimental Total Artificial Heart designed for smaller patients.

2 Jul 2015

UCLA patient first in California to receive smaller Total Artificial Heart

A petite 44-year-old woman has received a successful heart transplant at Ronald Reagan UCLA Medical Center, thanks to an experimental Total Artificial Heart designed for smaller patients.

2 Jul 2015

NDSU researcher awarded $1.35 million research grant to develop targeted treatment for colorectal cancer

A researcher at North Dakota State University, Fargo, is receiving a four-year $1.35 million research project grant from the National Cancer Institute of the National Institutes of Health to develop a targeted treatment for colorectal cancer.

2 Jul 2015

UCLA cardiologists use less invasive approach to replace heart valve

Last summer, after a long career as a successful entrepreneur and a brief retirement, Richard Whitaker was helping to start another new company. Unfortunately, a serious health concern caused a couple of interruptions in his work on the new venture. One of Whitaker's heart valves wasn't working properly, which caused congestive heart failure and led to two hospitalizations within several months.

2 Jul 2015

Study of genetic mutations could lead to optimized treatment plans for aplastic anemia patients

Scientists have identified a group of genetic mutations in patients with aplastic anemia, which likely will help doctors optimize treatment for this rare and deadly blood condition. The study, appearing in the New England Journal of Medicine, could lead to tailor-made treatment plans for aplastic anemia patients as part of the emerging precision medicine movement.

2 Jul 2015

Researchers receive $1.35 million grant to study how influenza virus passes from birds to humans

An international research team led by Lukas Tamm of the University of Virginia School of Medicine will receive $1.35 million from the Human Frontier Science Program Organization to better understand how the influenza virus passes from birds to humans.

2 Jul 2015

IBI scientists make progress in identifying new biomarkers for preventing colorectal cancer

Scientists from the Instituto de Investigación Biomédica [Institute of Biomedical Research], in Galicia (Spain), have made progress in the identification of new biomarkers for improving prevention of colorectal cancer.

1 Jul 2015

UVA Health System opens high-tech clinical genomics lab

The University of Virginia Health System has opened a high-tech clinical genomics lab that will personalize care for patients, help doctors determine the best treatments for cancers and other diseases, and allow UVA to offer the most cutting-edge clinical trials.

1 Jul 2015

NIBIB-supported researchers create platelet-like particles to control excessive bleeding, augment clotting

NIBIB-supported researchers have created tiny gel particles that can perform the same essential functions as platelets. The particles could one day be used to control excessive bleeding following traumatic injury or in individuals with impaired clotting due to an inherited condition or as a result of certain medications or chemotherapy.

1 Jul 2015

Lungs News and Research

Gene therapy improves lung function in patients with cystic fibrosis

Gene therapy for cystic fibrosis shows significant benefit in lung function

Boehringer Ingelheim’s Spiolto Respimat approved for COPD treatment in first European countries

NDSU's Stephen O'Rourke awarded NIH grant to conduct cardiovascular research

New study finds that cancer survivors who smoke have more barriers to quitting

FDA accepts Adaptimmune’s IND application for MAGE-A10 T therapeutic candidate to combat NSCLC

Mortality rates vary depending on socioeconomic differences among areas in Europe

UCLA patient successfully receives smaller Total Artificial Heart

UCLA patient first in California to receive smaller Total Artificial Heart

NDSU researcher awarded $1.35 million research grant to develop targeted treatment for colorectal cancer

UCLA cardiologists use less invasive approach to replace heart valve

Study of genetic mutations could lead to optimized treatment plans for aplastic anemia patients

Researchers receive $1.35 million grant to study how influenza virus passes from birds to humans

IBI scientists make progress in identifying new biomarkers for preventing colorectal cancer

UVA Health System opens high-tech clinical genomics lab

NIBIB-supported researchers create platelet-like particles to control excessive bleeding, augment clotting

Study explores effects of patent foramen ovale in high-altitude Bolivian setting

STIOLTO RESPIMAT Inhalation Spray now available for treatment of COPD across the U.S.

Retina contains microtubule "roadway" that provides energy required for visual processing

SLU's Center for Vaccine Development receives $2.9 million to study new vaccine to combat TB

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News